XORTX Therapeutics (XRTX) Cash & Equivalents (2020 - 2026)
XORTX Therapeutics (XRTX) posted Cash & Equivalents of $250275.0 for Q1 2026, down 71.05% on a QoQ basis from $864514.0 in Q4 2025, and down 86.79% year-over-year from $1.9 million in Q1 2025.
XORTX Therapeutics (XRTX) Cash & Equivalents (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $250275.0 for Q1 2026.
- Quarterly Cash & Equivalents fell 86.79% year-over-year to $250275.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $250275.0 (down 86.79% YoY) and the FY2025 annual result came in at $864514.0, down 65.05% from the prior year.
- Cash & Equivalents was $250275.0 for Q1 2026 at XORTX Therapeutics, down from $864514.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $12.2 million in Q1 2022 and bottomed at $250275.0 in Q1 2026.
- A 5-year average of $4.8 million and a median of $3.4 million in 2023 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 134.84% — and 2026, when it sank 86.79%.
- XORTX Therapeutics' Cash & Equivalents stood at $10.4 million in 2022, then slumped by 66.87% to $3.4 million in 2023, then fell by 28.25% to $2.5 million in 2024, then plunged by 65.05% to $864514.0 in 2025, then slumped by 71.05% to $250275.0 in 2026.
- Business Quant data shows XRTX's Cash & Equivalents at $250275.0 in Q1 2026, $864514.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | 250,275.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 250,275.00 |
| Dec 31, 2025 | 864,514.00 |
| Sep 30, 2025 | 1.19 Mn |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Dec 31, 2023 | 3.45 Mn |
| Sep 30, 2023 | 5.07 Mn |
| Jun 30, 2023 | 6.16 Mn |
| Mar 31, 2023 | 7.91 Mn |
| Dec 31, 2022 | 10.41 Mn |
| Sep 30, 2022 | 9.32 Mn |
| Jun 30, 2022 | 10.53 Mn |
| Mar 31, 2022 | 12.24 Mn |
| Dec 31, 2021 | 14.96 Mn |
| Sep 30, 2021 | 3.97 Mn |
| Dec 31, 2020 | 131,374.22 |